Abstract
As demand for data-driven preventive healthcare grows globally, US-built digital health platforms face significant barriers when entering highly regulated European markets. This study examines whether HealthPrevent360 (HP360), an AI-powered preventive health platform, can successfully enter Germany's statutory healthcare system, and proposes a concrete market entry strategy to make it possible. Using a mixed-methods approach combining Porter's Five Forces analysis, SWOT assessment, comparative US-Germany healthcare systems research, consumer surveys, and in-depth interviews with German residents and a Techniker Krankenkasse (TK) industry partner, we find that HP360 cannot enter Germany in its current form. Key barriers include GDPR compliance, EU data sovereignty requirements, medical device classification, and deep cultural resistance to US-origin health apps. However, primary research also reveals that German consumers and institutions are genuinely open to digital health innovation when trust, transparency, and regulatory compliance are guaranteed. We recommend an "Adopt and Enter" strategy — transforming these barriers into competitive advantages through three phases: legal and structural Germanification, earning medical and public trust, and embedding into German healthcare infrastructure via a strategic partnership with Techniker Krankenkasse, Germany's largest statutory insurer. Our findings suggest that full regulatory and cultural commitment, rather than minimal adaptation, is HP360's most viable and defensible path to market leadership in Germany.